AI Visibility Scorecard
KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa
keytruda.com · Healthcare
Borderline visible. AI engines can read KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa, but Structured Data, E-E-A-T Signals and Domain Trust are weak, so it is at real risk of being skipped when buyers ask ChatGPT, Claude or Perplexity for a recommendation.
AI engines read this profile 13 times
Claude · Parallel · Meta AI · Perplexity
Top 1% in Healthcare for AI visibility
83
AI Naming Predictability
iNamed sometimes · 83/100
Healthcare average 11
Top 1% of Healthcare
See what's behind this score →5.87
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →0
0
About KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa
from our crawl and measurement
KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa is one of the businesses we track in the Healthcare space. Its AI visibility score is 5.87 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found structured data on the page (Substance, MedicalWebPage, MedicalAudience) and a readable heading structure. It is missing an llms.txt file and a sitemap.
AI crawlers have read this profile 13 times in our tracking, including ClaudeBot (Anthropic), ShapBot (Parallel) and Meta AI.
- Company ·
- KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa
- Website ·
- keytruda.com
- Industry ·
- Healthcare
- Site status ·
- Live (The website showed an active business site when last checked (Oct 31, 2026).)
- Last scored ·
- Nov 9, 2026
The 6 on-page signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
The 6 off-page signals AI reads
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
-
Not yet measured.
News & Press
Fair
Press and news coverage.
Community
Weak
No community discussion yet.
Social Mentions
Good
Social discussion and mentions.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 5.87/10, KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa is borderline: readable but under-signaled. That is fixable, and the signals above are where to start.
How to Get Your Company Named by ChatGPT, Gemini, and Claude
When a buyer asks ChatGPT which company to use, two different things can happen. ChatGPT can name a company in its answer. Or it can link to a web page as a source. Most advice about AI visibility is about the second one. Our data says the first one is what matters.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa.
Source & Attribution
Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/keytruda
Cite this score: Engagemii (2026). "AEO Score for KEYTRUDA® (pembrolizumab) & KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa." Retrieved from https://engagemii.com/aeo/brands/keytruda
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform